Search for: "Boehringer Ingelheim Pharmaceuticals"
Results 41 - 60
of 252
Sort by Relevance
|
Sort by Date
12 Apr 2017, 2:22 pm
One hopes that Boehringer Ingelheim Pharmaceuticals (Pradaxa) or Janssen Pharmaceuticals (Xarelto) or one of the other responsible drug companies have such a drug-safety study currently underway or planned to begin soon. [read post]
21 Mar 2017, 12:23 pm
Boehringer Ingelheim Pharmaceuticals, Inc. markets this prescription anticoagulant drug. [read post]
30 Dec 2016, 2:58 pm
Permission to appeal in patent cases - farewell to the Pozzoli approachGuest Kat Eibhlin Vardy recaps the case Teva UK Ltd v Boehringer Ingelheim Pharma GmbH & Co KG, [2016] EWCA Civ 1296. [read post]
17 Sep 2016, 7:08 am
Specifically, the decision is being lauded by Boehringer Ingelheim, the makers of Pradaxa, according to a recent news feature from FiercePharma. [read post]
17 Sep 2016, 7:08 am
Specifically, the decision is being lauded by Boehringer Ingelheim, the makers of Pradaxa, according to a recent news feature from FiercePharma. [read post]
22 Aug 2016, 1:05 pm
About Pradaxa Pradaxa, also known as Dabigatran, is manufactured by Boehringer Ingelheim Pharmaceuticals and is prescribed to help prevent the blood from coagulating or clotting. [read post]
10 Aug 2016, 1:27 pm
The drug was produced by German manufacturer Boehringer Ingelheim Pharmaceuticals as a substitute to the drug warfarin. [read post]
10 Aug 2016, 1:27 pm
The drug was produced by German manufacturer Boehringer Ingelheim Pharmaceuticals as a substitute to the drug warfarin. [read post]
5 Aug 2016, 2:10 pm
Current Product Liability Litigation Cases Which Involve Popular Drugs With Serious Side Effects That Are Starting To Gain More Attention (Posted by Tom Lamb at DrugInjuryWatch.com) This article will feature three types of drug injury cases that are starting to gain some momentum in terms of the number of lawsuits filed against the responsible pharmaceutical companies in courts across the country. (1) Diabetes Medicines in the Sodium-Glucose Co-Transporter-2 (SGLT2) Inhibitors… [read post]
13 Jul 2016, 1:56 pm
About a month later, however, only those three diabetes drugs from Boehringer Ingelheim Pharmaceuticals, Inc. [read post]
30 Jun 2016, 12:12 pm
“For dabigatran [Pradaxa, Boehringer Ingelheim]-treated patients, idarucizumab [Praxbind, Boehringer Ingelheim], a monoclonal antibody that binds dabigatran and acutely reverses its anticoagulation effect, is currently approved for major bleeding or for patients requiring emergency procedures, and is available in many countries,” Levy and Hunt wrote. [read post]
3 Jun 2016, 10:50 am
“Boehringer Ingelheim to Settle 4,000 Pradaxa Lawsuits for $650 Million. [read post]
8 May 2016, 9:59 pm
KG; Boehringer Ingelheim International GmbH; Boehringer Ingelheim Pharmaceuticals, Inc. [read post]
31 Mar 2016, 6:40 am
" Dr Peters, who also writes a column for Medscape Diabetes & Endocrinology, has served as a speaker or consultant with Eli Lilly, Boehringer Ingelheim Pharmaceuticals, and AstraZeneca Pharmaceuticals, which make SGLT-2 inhibitors. [read post]
26 Feb 2016, 7:20 am
These SGLT2 drugs are currently approved for use by patients in the US: Invokana (canagliflozin) — Janssen Pharmaceuticals — FDA Approval: 2013 Invokamet (canagliflozin and metformin) — Janssen Pharmaceuticals — FDA Approval: 2014 Farxiga (dapagliflozin) — AstraZeneca Pharmaceuticals — FDA Approval: 2014 Xigduo XR (dapagliflozin and metformin extended-release) — AstraZeneca Pharmaceuticals — FDA Approval: 2014… [read post]
24 Jan 2016, 6:11 am
, lawsuits are swarming around the creators of the drugs (Bristol-Myers Squibb and Otsuka Pharmaceuticals for Abilify, Pfizer and Boehringer Ingelheim for Mirapex). [read post]
8 Jan 2016, 8:00 pm
Boehringer Ingelheim Pharmaceuticals v. [read post]
24 Dec 2015, 6:43 am
On the eve of trial, Boehringer Ingelheim agreed to pay $650 million in Pradaxa settlements, with an average of about $150,000 per claim. [read post]
22 Dec 2015, 7:03 am
On the eve of trial, Boehringer Ingelheim agreed to pay $650 million in Pradaxa settlements, with an average of about $150,000 per claim. [read post]
4 Nov 2015, 9:34 am
According to a recent news article from the Washington Post, a federal watch group reports the United States Food and Drug Administration (FDA) exercised “lax” judgment and made “questionable” decisions to be accommodating to the pharmaceutical maker Boehringer Ingelheim when reviewing its application for the anticlotting medication known as Pradaxa. [read post]
